Drugs / HerinCAR-PD1 cells
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02873390 | Aug 2016 → Mar 2018 | cancer | Ningbo Cancer Hospital | Unknown | No outcome recorded |
| Phase 1/2 | NCT02862028 | Aug 2016 → Mar 2018 | neoplasm | Shanghai International Medical Center | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HerinCAR-PD1 cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02862028 ↗ |
| Modality | Cell therapy | “cell therapy using herinCAR-PD1 cells” NCT02862028 ↗ |
| Route | Intravenous | “IV (in the vein) for each infusion” NCT02862028 ↗ |